Status:
UNKNOWN
Sonazoid Enhanced Liver Cancer Trial for Early Detection
Lead Sponsor:
Kindai University
Conditions:
Hepatocellular Carcinoma
Liver Cirrhosis
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The aim of this study is to prove usefulness of contrast-enhanced ultrasound (CE-US) using Sonazoid (TM) in the early detection of HCC as compared with conventional B-mode ultrasound (B-mode US) for h...
Eligibility Criteria
Inclusion
- Age over 20
- HBV or HCV related liver cirrhosis
- No history of HCC
- Diagnosed as liver cirrhosis histologically or clinically Histologically confirmed by liver biopsy Confirmed by formula of diagnosing cirrhosis Radiological finding Finding of portal hypertension Platelet\<130,000
- Inpatient or outpatient
- Patients who signed a written informed consent form
Exclusion
- History of hypersensitivity to egg yolk
- Pregnant or lactating women and women who may be pregnant
- Severe liver dysfunction(AST, ALT,or BIL level \>10ULN
- Associated with HCC
- Patients receiving interferon
- Age under 20
- Judged by investigator not to be appropriate for inclusion in this study
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT00822991
Start Date
January 1 2009
End Date
December 1 2019
Last Update
December 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kinki University School of Medicine, Department of Gastroenterology and Hepatology
Ōsaka-sayama, Osaka, Japan, 589-8511